Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
Immuneering (IMRX) Newsfilter·2025-01-13 21:00Immuneering (IMRX) Newsfilter·2025-01-13 21:00
R1Immuneering (IMRX) Newsfilter·2025-01-13 21:00